SuperworthCDT Equity market cap CDT
Share price times shares outstanding: what the whole company sells for, since 2023.
- Today, Oct 23, 2026
- $4.1K
- Highest close in our data
- $20.6M
- Dec 2023
CDT Equity is worth $4.1K at the close on Oct 23, 2026, at $0.13 a share.
That is down 66% over the last year.
Its highest close in our data was $20.6M in Dec 2023.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $4.1K | $2.5K | $672.4K | −96% |
| 2025 | $93.2K | $10K | $507.3K | −62% |
| 2024 | $247.2K | $247.2K | $15.1M | −98% |
| 2023 | $13.3M | $262.4K | $20.6M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest CDT Equity's size, closest first, today.
| Company | Market cap |
|---|---|
| CDTCDT Equity | $4.1K |
| SBFMSunshine Biopharma | $581.6K |
| DCOYDecoy Therapeutics | $635.5K |
| JAGXJaguar Health | $702.9K |
| LABTLakewood-Amedex Biotherapeutics | $734.6K |
| NXTSNexentis Technologies | $761.8K |
| VBIOValion Bio | $834.3K |
| ARTLArtelo Biosciences | $1.3M |
| LNAILunai Bioworks | $1.5M |
| GNPXGenprex | $1.5M |
| GOVXGeoVax Labs | $1.5M |
| Peer median | $798.1K |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on CDT Equity
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.